[Construction of reversed caspase-3 and it's effect on apoptosis induction in human lung adenocarcinoma cell line A549].
Rui Zhou, Wei Long, Ping Chen
Abstract
Rui Zhou, Wei Long, Ping Chen
Abstract
OBJECTIVE: To investigate the effect of reversed caspase-3 expression vector on apoptosis of human lung adenocarcinoma cell line A549. METHODS: Reversed pcDNA 3.1-rev-caspase-3 plasmid and wild type pcDNA3.1-caspase-3 plasmid were constructed by genetic recombination. Three experiments (groups) with A549 cells were carried out: a group of transfection with pcDNA 3.1-rev-caspase plasmid, a group of transfection with pcDNA 3.1-caspase plasmid, and a control group of transfection with pcDNA 3.1 plasmid. Intervention with DEVD-fmk, an inhibitor of caspase-3, was carried out in the first two groups. The activity of caspase-3, the apoptosis and the growth of A549 cells were measured. RESULTS: (1) The activity of caspase-3 in the pcDNA 3.1-rev-caspase-3 plasmid group and pcDNA 3.1-caspase-3 plasmid group was (11.87 +/- 0.92)% and (5.34 +/- 0.38)%, respectively, significantly higher in the former group (t = 16.02, P < 0.01). After intervention with DEVD-fmk, the activity of caspase-3 in pcDNA 3.1-rev-caspase-3 plasmid group and in pcDNA 3.1-caspase-3 plasmid group was (7.04 +/- 0.48)% and (4.51 +/- 0.20)%, respectively, also significantly higher in the former group (t = 11.86, P < 0.01). (2) Flow cytometry showed that the apoptosis rate of A549 cells in pcDNA 3.1-rev-caspase-3 plasmid group, pcDNA 3.1-caspase-3 plasmid group and pcDNA 3.1 plasmid group was (20.1 +/- 3.5)%, (7.8 +/- 2.8)% and (1.4 +/- 0.3)%, respectively. The difference of the apoptosis rate was significant (F = 44.01, P < 0.01). (3) The survival rates of A549 cells in the pcDNA 3.1-rev-caspase-3 plasmid group, pcDNA 3.1-caspase-3 plasmid group and pcDNA 3.1 plasmid group were (35.7 +/- 1.1)%, (72.8 +/- 2.9)% and (85.4 +/- 4.8)%, respectively. The survival rate of A549 cells in pcDNA 3.1-rev-caspase-3 plasmid group was lower than those in the other two groups (F = 375.07, P < 0.01). CONCLUSIONS: pcDNA 3.1-rev-caspase-3 in A549 cells has a strong activity and can resist caspase-3 inhibitor in A549 cells. It can also induce A549 cell apoptosis and inhibit the growth of A549 cells.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To investigate the effect of reversed caspase-3 expression vector on apoptosis of human lung adenocarcinoma cell line A549. METHODS: Reversed pcDNA 3.1-rev-caspase-3 plasmid and wild type pcDNA3.1-caspase-3 plasmid were constructed by genetic recombination. Three experiments (groups) with A549 cells were carried out: a group of transfection with pcDNA 3.1-rev-caspase plasmid, a group of transfection with pcDNA 3.1-caspase plasmid, and a control group of transfection with pcDNA 3.1 plasmid. Intervention with DEVD-fmk, an inhibitor of caspase-3, was carried out in the first two groups. The activity of caspase-3, the apoptosis and the growth of A549 cells were measured. RESULTS: (1) The activity of caspase-3 in the pcDNA 3.1-rev-caspase-3 plasmid group and pcDNA 3.1-caspase-3 plasmid group was (11.87 +/- 0.92)% and (5.34 +/- 0.38)%, respectively, significantly higher in the former group (t = 16.02, P < 0.01). After intervention with DEVD-fmk, the activity of caspase-3 in pcDNA 3.1-rev-caspase-3 plasmid group and in pcDNA 3.1-caspase-3 plasmid group was (7.04 +/- 0.48)% and (4.51 +/- 0.20)%, respectively, also significantly higher in the former group (t = 11.86, P < 0.01). (2) Flow cytometry showed that the apoptosis rate of A549 cells in pcDNA 3.1-rev-caspase-3 plasmid group, pcDNA 3.1-caspase-3 plasmid group and pcDNA 3.1 plasmid group was (20.1 +/- 3.5)%, (7.8 +/- 2.8)% and (1.4 +/- 0.3)%, respectively. The difference of the apoptosis rate was significant (F = 44.01, P < 0.01). (3) The survival rates of A549 cells in the pcDNA 3.1-rev-caspase-3 plasmid group, pcDNA 3.1-caspase-3 plasmid group and pcDNA 3.1 plasmid group were (35.7 +/- 1.1)%, (72.8 +/- 2.9)% and (85.4 +/- 4.8)%, respectively. The survival rate of A549 cells in pcDNA 3.1-rev-caspase-3 plasmid group was lower than those in the other two groups (F = 375.07, P < 0.01). CONCLUSIONS: pcDNA 3.1-rev-caspase-3 in A549 cells has a strong activity and can resist caspase-3 inhibitor in A549 cells. It can also induce A549 cell apoptosis and inhibit the growth of A549 cells.
Key concepts: Plasmid, Transfection, Apoptosis, A549 cell, Molecular biology, Caspase 3, Flow cytometry, Biology